[EN] SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF<br/>[FR] SPIRO-LACTAME MODULATEUR DE RÉCEPTEURS NMDA ET LEURS UTILISATIONS
申请人:APTINYX INC
公开号:WO2019152696A1
公开(公告)日:2019-08-08
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders as well as other disorders.